Gallery Drug

Access Oncology is a fully integrated biopharmaceutical company based in New York, NY, dedicated to advancing new hope for people with kidney disease. Their team works tirelessly to address complications associated with kidney disease and has developed a commercially available medicine, as well as a late-stage oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) called vadadustat, based on Nobel Prize-winning science. With a mission to protect the kidneys and innovate for better lives, Access Oncology is a trusted leader in the renal community, delivering unique products to patients with kidney disease. Although vadadustat is approved for use in 34 countries, it has not yet received approval from the U.S. Food and Drug Administration.Generated from the website

At Back and Body Medical, we have a staff made up of a medical doctor, a chiropractor, and a group of licensed physical therapists. We also have an X-ray machine on the premises and the knowledge and experience to diagnose any injury. Our collaborative care approach enables us to diagnose and treat many conditions all under one roof.